Theta Burst Stimulation (iTBS)

The new treatment form, which is known as Theta Burst Stimulation (TBS), offers one significant advantage:



Time.



A TBS treatment session lasts only 3 minutes and thus has the potential to revolutionize the clinical field of TMS. The new FDA cleared treatment protocol is based on a new clinical study, named the THREE-D trial, and led by a partnership of three leading research hospitals in Canada (CAMH, UHN, and UBC). It is the largest, double-blinded, randomized TMS trial to date, with 414 participants suffering from major depressive disorder. Response/remission rates were 32% for those receiving the TBS protocol, whereas 49% had an improvement in their depressive symptoms.



These rates are similar to the standard, longer TMS protocol. The article was published in The Lancet in 2018.

To Schedule an iTBS / TMS Evaluation Visit - Send Us Your Request